160 related articles for article (PubMed ID: 17075277)
1. Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis.
Manki A; Nishikomori R; Nakata-Hizume M; Kunitomi T; Takei S; Urakami T; Morishima T
Allergol Int; 2006 Sep; 55(3):337-41. PubMed ID: 17075277
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
[TBL] [Abstract][Full Text] [Related]
3. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.
Aganna E; Zeharia A; Hitman GA; Basel-Vanagaite L; Allotey RA; Booth DR; Hawkins PN; Thacker C; Syndercombe-Court D; McDermott MF
Arthritis Rheum; 2002 Jan; 46(1):245-9. PubMed ID: 11817598
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
Front Immunol; 2020; 11():576152. PubMed ID: 33162992
[No Abstract] [Full Text] [Related]
5. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
[TBL] [Abstract][Full Text] [Related]
6. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
7. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
[TBL] [Abstract][Full Text] [Related]
9. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
[TBL] [Abstract][Full Text] [Related]
10. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.
Dodé C; André M; Bienvenu T; Hausfater P; Pêcheux C; Bienvenu J; Lecron JC; Reinert P; Cattan D; Piette JC; Szajnert MF; Delpech M; Grateau G;
Arthritis Rheum; 2002 Aug; 46(8):2181-8. PubMed ID: 12209523
[TBL] [Abstract][Full Text] [Related]
11. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
12. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
14. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
[TBL] [Abstract][Full Text] [Related]
16. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
[TBL] [Abstract][Full Text] [Related]
17. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
18. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
[TBL] [Abstract][Full Text] [Related]
19. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
Huggins ML; Radford PM; McIntosh RS; Bainbridge SE; Dickinson P; Draper-Morgan KA; Tighe PJ; Powell RJ; Todd I
Arthritis Rheum; 2004 Aug; 50(8):2651-9. PubMed ID: 15334481
[TBL] [Abstract][Full Text] [Related]
20. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family.
Weyhreter H; Schwartz M; Kristensen TD; Valerius NH; Paerregaard A
J Pediatr; 2003 Feb; 142(2):191-3. PubMed ID: 12584543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
